Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 36.4218.0322.34159.317.95

What is the latest EV/Core EBITDA ratio of ORCHID PHARMA ?

The latest EV/Core EBITDA ratio of ORCHID PHARMA is 36.42 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202436.42
Mar202318.03
Mar202222.34
Mar2021159.31
Mar20207.95

How is EV/Core EBITDA of ORCHID PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2024 36.42
102.00
Mar2023 18.03
-19.29
Mar2022 22.34
-85.98
Mar2021 159.31
1,903.90
Mar2020 7.95 -

Other Financial Ratios of ORCHID PHARMA


Compare EV/Core EBITDA ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹3,573.8 Cr -1.1% -4.6% -49.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,273.0 Cr 2.5% 4.1% -0.8% Stock Analytics
DIVIS LABORATORIES ₹176,604.0 Cr 0.5% -2.9% 35.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,316.0 Cr 6.2% 9.3% 17.9% Stock Analytics
CIPLA ₹125,993.0 Cr 4.9% 2.9% 1.3% Stock Analytics
DR REDDYS LABORATORIES ₹107,795.0 Cr 2.1% 1.2% -5% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-1.1%

-4.6%

-49.2%

SENSEX

-1.5%

-2.5%

0.2%


You may also like the below Video Courses